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Abstract
Background: Consensus for methicillin-resistant Staphylococcus aureus (MRSA) control has still not been reached. We
hypothesised that use of rapid MRSA detection followed by contact precautions and single room isolation would reduce
MRSA acquisition.
Methods: This study was a pre-planned prospective interrupted time series comparing rapid PCR detection and use of long
sleeved gowns and gloves (contact precautions) plus single room isolation or cohorting of MRSA colonised patients with a
control group. The study took place in a medical-surgical intensive care unit of a tertiary adult hospital between May 21st
2007 and September 21st 2009. The primary outcome was the rate of MRSA acquisition. A segmented regression analysis
was performed to determine the trend in MRSA acquisition rates before and after the intervention.
Findings: The rate of MRSA acquisition was 18.5 per 1000 at risk patient days in the control phase and 7.9 per 1000 at-risk
patient days in the intervention phase, with an adjusted hazard ratio 0.39 (95% CI 0.24 to 0.62). Segmented regression
analysis showed a decline in MRSA acquisition of 7% per month in the intervention phase, (95%CI 1.9% to 12.8% reduction)
which was a significant change in slope compared with the control phase. Secondary analysis found prior exposure to
anaerobically active antibiotics and colonization pressure were associated with increased acquisition risk.
Conclusion: Contact precautions with single room isolation or cohorting were associated with a 60% reduction in MRSA
acquisition. While this study was a quasi-experimental design, many measures were taken to strengthen the study, such as
accounting for differences in colonisation pressure, hand hygiene compliance and individual risk factors across the groups,
and confining the study to one centre to reduce variation in transmission. Use of two research nurses may limit its
generalisability to units in which this level of support is available.
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Introduction
Contact precautions and single room isolation are often
regarded as the sine qua non of prevention of transmission of
methicillin-resistant Staphylococcus aureus (MRSA) [1], however, this
is not universally accepted or practised [2]. Recently, some have
questioned strategies that target individual healthcare-associated
pathogens, as they are time and resource intensive, compared with
using generic population-based interventions, such as hand
hygiene, antibiotic stewardship, and care bundles [3,4]. Many
studies conclude that contact precautions are essential for MRSA
control [5,6], although there are a number of studies that cast
doubt on the necessity [4,7,8] and efficacy [9] of contact
precautions to control MRSA. For example, results from the
paper proposing that a ‘‘program of universal surveillance, contact
precautions, hand hygiene, and institutional culture change was
associated with a decrease in health care–associated transmissions
of and infections with MRSA in a large health care system’’ have
been challenged by mathematical modelling suggesting that the
control program could have only contributed marginally to the
reduction in infections that was reported [10]. Despite guidelines
intended to raise standards of reporting and research, the infection
control literature remains methodologically poor with inadequate
data and inappropriate analyses common [11]. Only one study
that we are aware of has examined the effectiveness of isolation
precautions alone. This study found that single room isolation with
glove and gown use could modestly reduce MRSA transmission,
although the estimate has considerable uncertainty and the study
did not account for other factors such as hand hygiene compliance
[12].
At our institution, MRSA is endemic. Contact precautions are
not usually used when managing MRSA colonised patients.
Neither active surveillance nor contact precautions are mandated
in the state of Victoria. We performed a quasi-experimental
research study in our intensive care unit (ICU) population between
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May 21st 2007 and September 21st 2009. Our hypothesis was that
MRSA acquisition would be reduced if single room isolation (or
cohorting) accompanied by use of gowns and gloves for MRSA
colonized/infected patients (identified via active surveillance using
rapid detection methods) were used in an ICU compared with a
pre-intervention control group in whom these precautions were
not used.
Methods
Design overview
This study was a planned, prospective interrupted time series,
with a pre-specified date for change in management after 14
months of study, not related to outcome measures. The study was
formally implemented as a research study with predefined protocol
and endpoints and was initiated by the researchers with no
institutional imperative. The study was performed to answer one
specific question and the intervention was not influenced or
triggered by rates of MRSA, clinical outcomes or any other
unspecified influence. The study took place between May 21st
2007 and September 21st 2009, with a change-over date of 21st
July 2008.
Setting and participants
The Royal Melbourne Hospital (RMH) is a university-affiliated
tertiary adult hospital with 350 beds. The medical-surgical ICU
consists of 24 beds, six single and 18 open-bay. Surgical patients,
consisting of trauma, cardiothoracic, neurosurgery, and general
specialities, comprise 70% of ICU admissions. Other specialities at
RMH include haematology/oncology, bone marrow transplanta-
tion and renal transplantation. Post-operative cardiothoracic
surgery patients are admitted to this ICU routinely for monitoring.
Nurse-to-patient ratios in ICU are 1:1 except for patients in step-
down care for whom the ratios are 1:2. The infection control
service made regular visits to the ICU during the study period.
Consecutive patients admitted to the RMH ICU during the
study period were included. The study observed 4317 patients,
admitted 4781 times. The source of admission was from home in
80% of patients, a chronic care institution in 1% and other
hospitals for the remainder. The crude mortality rate of patients
was 7.6%.
The study was approved by the Melbourne Health Human
Research Ethics Committee. The committee did not require that
individual patient consent be sought as the study was considered to
be a quality improvement initiative.
Screening and intervention
In both study phases, patients were screened for MRSA, but
results were not specifically acted upon in the control phase.
Results were available to clinicians but no specific infection control
precautions were used; instead patients with MRSA colonization
were managed according to usual hospital practice, as follows.
Staff were required to wear plastic aprons for all patient contact.
Contact precautions were not routinely used when caring for
MRSA colonized or infected patients and isolation/cohorting was
not practiced. On the rare occasion where a patient was deemed to
be likely to shed high quantities of MRSA, such as an MRSA
positive wound with discharge that could not be contained, he/she
would be cared for with contact precautions and isolation/
cohorting, although this almost never occurred. Use of alcohol-
based hand rub solution (ABHRS) was hospital policy for hand
disinfection. Hand hygiene was actively promoted, with regular
compliance monitoring and feedback. MRSA decolonization was
not routinely used. Antibiotic management of patients in the ICU
was not altered for the purposes of the study.
In the intervention phase, results of MRSA screening were
conveyed to the ward by telephone and colonized patients were
cared for using contact precautions and isolation/cohorting,
detailed in Table 1. The only change during the study period
was introduction of the study intervention. During both phases of
the study, research nurses were employed to ensure compliance
with swabbing, contact precautions and isolation/cohorting as well
as data collection. During most of the study, this involved seven
days per week of nursing time.
Nose, throat, groin, and axilla swabs were taken on admission,
Monday, Thursday and discharge (or within 48 hours of
discharge) in both study phases. Swabs were cultured in both
phases. In the intervention phase, swabs were additionally
processed using polymerase chain reaction (PCR). Culture results
were used to determine the study outcome (MRSA acquisition) in
both phases. PCR results were used only to determine isolation
status of patients during the intervention phase and were not used
in outcome calculations to ensure that detection bias did not occur
if PCR and culture had different sensitivities for detecting MRSA.
If a patient was detected to be MRSA positive either via clinical
culture or screening swab culture, this was also used to determine
isolation status (although most patients that were positive on
clinical culture had already been detected using PCR and were
thus already in contact precautions). During the intervention
phase, positive results obtained via PCR or via culture were
telephoned through to the ICU when available and patients were
placed in contact precautions as soon as possible.
Hand hygiene and infection control compliance
monitoring
Observations of compliance with hand hygiene and infection
control precautions were made for one hour per week on most
weeks throughout the study. Hand hygiene compliance monitor-
ing, based on methodology used in other studies [8], was the
proportion of perceived opportunities in which appropriate hand
hygiene was observed. For infection control observations, compli-
ance was reported as the proportion of times healthcare workers
used gloves or long sleeved gowns on each occasion that the
precautions were indicated, appropriate to the task or additional
precautions that were being used for each patient.
Microbiologic methods
In both study phases, patients were swabbed using BD culture
swabsTM in liquid Stuart’s medium (Becton Dickinson). Cultures
were performed on chromogenic MRSA media (Chrom-ID
MRSATM bioMe´rieux). Identification of S. aureus was based on
production of heat stable DNase, supplemented by a secondary
mannitol fermentation agar plate. Sensitivity testing was per-
formed using agar dilution.
In the intervention phase, swabs were cultured using the same
methods as in the control phase. Nose and groin swabs were also
processed using the IDI-MRSA assay (Infectio Diagnostic, Inc.,
Sainte-Foy, Quebec, Canada) with the Smart Cycler II rapid
DNA amplification system (Cepheid, Sunnyvale, CA) [13].
In order to determine the relatedness of isolates and whether
isolates were clustered, they were typed using pulsed field gel
electrophoresis (PFGE). MRSA screening isolates from both study
phases were frozen at 280uC. PFGE of Sma1 digested genomic
DNA of the isolates was performed as described previously [14].
Digital images of the gels were analysed with GelCompar software
(Applied Maths, Belgium). Isolates with similarity of 80% or more
were considered a clonal cluster.
Prevention of MRSA Infection in ICU Patients
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Definitions
MRSA acquisition was defined in three ways:
1). New colonization using screening swabs only: conversion
from negative to positive in patients who had $2 sets of
screening swabs taken.
2). New colonization using screening and clinical specimens:
initial negative screening swabs and subsequent positive
screening or clinical specimens in patients who had one set of
screening swabs and a subsequent clinical sample or
screening sample.
3). New infection: one negative screening swab and subsequent
infection in patients who had at least one negative set of
screening swabs.
A clinical specimen was defined as one sent on clinical
indication. If a patient had known MRSA found on a clinical
specimen in the six months prior to ICU admission, they were not
included as an acquisition even if their first set of swabs was
negative.
At risk patient day was defined as a day in which one patient
who was not MRSA colonised or infected spent on the ward, for
whom screening swabs were performed before and after.
MRSA infection was determined using Australian Infection
Control Association definitions; that is, a sterile site isolate or a
non-sterile site clinical isolate and MRSA specific antibiotic
therapy administered by a clinician [15]. Infections were
determined by the research nurse with review by one of the
investigators (CM). Daily colonization pressure was defined as high
if two or more patients in the ICU had MRSA colonisation or
infection.
Sample size estimation
Based on a known 6.9% MRSA colonization prevalence at
RMH ICU discharge [17], of which 60% are estimated to have
been acquired during the ICU stay (extrapolating from a previous
study at another Melbourne hospital) [18], we calculated 1239
patients were needed in each group to detect a decrease in
acquisition from 4% to 2% with 80% power. We planned to
screen 1500 patients in each group, inflating the study numbers to
allow for loss of precision in the estimates owing to fluctuations in
prevalence (due to serial dependence) [19] during the study. The
study had an 80% power to detect a significant difference in
hazard with a two tailed P value of 0.05, assuming a hazard ratio
of 0.5. In order to achieve this power, we required a minimum of
50 events in the first phase. As such we determined to continue the
pre-intervention observation phase until at least 12 months or at
least 50 acquisitions were observed, whichever was the longer
period. A review at 11 months determined the threshold of 50
acquisitions had not been reached and both phases were reset to a
14 month duration. The final number of individuals screened at
least twice, and hence included in the analysis, exceeded 1800 in
each group.
Statistical analysis including outcomes
Primary analysis was the hazard ratio; pre- and post-
intervention for the individual hazard of MRSA, defined as
acquisition per at-risk patient day, after adjusting for pre-defined
covariates. Time-varying covariates (exposure to antibiotics, time
since admission, colonization pressure, hand hygiene compliance,
bed occupancy, phase of study, patient-to- nurse ratio) and time-
constant covariates (age, gender, APACHEII score, medical unit)
Table 1. Study characteristics and intervention.
Setting: 24 bed medical-surgical ICU in adult tertiary hospital Dates: 21st May 2007 to 21st
September 2009
Population characteristics: Unselected consecutive ICU
admissions. Endemic MRSA.
Major intervention: Change from usual care of MRSA colonized/infected patients (standard precautions and single-use plastic aprons as for all ICU patients) to active
surveillance, single room/cohorting plus long-sleeved gowns and gloves (contact precautions) for MRSA colonized/infected patients
Active surveillance Results Contact precautions Isolation policy
Phase 1 (Control Phase)
21/5/2007–20/7/2008
Screening for MRSA (nose,
throat, groin, axilla)
Aprons for all patients, no contact
precautions for MRSA patients*
No isolation for MRSA
patients unless
shedders *
Culture only
Results available on
electronic pathology
records but not actively
communicated or
specifically acted upon
Phase 2 (Intervention Phase)
21/7/2008–21/9/2009
Screening for MRSA
(nose, throat, groin, axilla)
Contact precautions (long-sleeved
gowns, gloves) for MRSA patients
Single room or
cohorting with other
MRSA patients
Culture+PCR
Results rung through to nurse
in charge as soon as available
Antibiotic policy (both phases): No change during study period
MRSA decolonization policy (both phases): Not used during study period
Pre-emptive isolation (both phases): Not used during study period
Hand hygiene policy and intervention: Alcohol based hand rub in all patient cubicles. Regular hand hygiene audits that did not change during the study period.
Primary study outcome: Proportion of patients that acquired MRSA, MRSA attack rate (new acquisitions per 1000 at-risk patient days)
*Unless on risk assessment deemed to be a high-shedder, where contact precautions would be used (but rarely enacted).
doi:10.1371/journal.pone.0058112.t001
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were chosen based on findings from previous studies
[8,9,16,18,20,21,22,23] and specified a priori.
Each individual in the study was analysed as an independent
study participant. The assumed independence was conditional on
the covariates for each participant, including daily colonization
pressure. Incorporating time-varying covariates required daily
updating of these covariates for each patient. The hazard of
MRSA acquisition was calculated for each patient day. The
hazard on day t for patient ‘i’ is given by
li(t)~l0(t)ai exp(bXi(t))
where Xi (t) is the vector of covariates for individual i on day t and
b is the vector of coefficients. l0 (t) is the baseline hazard on day t
(the hazard if all other variables are zero) and ai is the shared
frailty of individual i over all of that individual’s admissions. A
proportional hazards assumption was used in the analysis and test
of this assumption made using Schoenfeld residuals [24], showing
proportional hazards could be assumed (P= 0.30). The primary
outcome for this study was the hazard ratio for the effect of the
intervention phase on an at-risk individual’s daily risk of MRSA
acquisition, after adjusting for covariates. Analysis was performed
using STATA/SE 11.0 (StataCorp LP).
Segmented regression analysis
We used a model of segmented regression, allowing for a step
change and the time of the intervention, and estimated parameters
based on an assumed proportional reduction (or increase) over
time. Our modelled incidence per 1000 at-risk patient days on
month m is given by inc(m) = inc (m21) pc for the control phase,
where pc is the proportional change each month in the control
phase and inc (m) = inc (m21) pi for the control phase, where pi is
the proportional change each month in the intervention phase. At
two points in the time series, the incidence was assumed not to
depend on the previous month’s incidence, namely inc(1) = a the
intercept, the incidence at the start of the study, and is estimated as
a separate parameter, and inc (15) = b is the estimated starting
incidence of the intervention phase.
The parameter estimates were made using a Bayesian inference
framework, which allowed for estimation of functions of param-
eters, including estimated incidence at the time of the intervention
(a pc
14) and the end of the intervention (b pi
14) and the estimated
difference between them. Non-negative uniform priors were
assumed for all parameters and a Poisson error function for the
observed incidence (given the modelled incidence) was used to
construct the likelihood function. Burn-in of 10000 iterations and
parameter acquisition of 90000 iterations was used.
Analysis of Staphylococcal bacteraemia
Using the same methodology as described above, we analysed
the rates of MRSA and MSSA bacteraemia in the hospital. We
assessed for changes in incidence both at the time of the
intervention and over time following the intervention.
Results
Demographics, testing frequency, and patient characteristics
other than the intervention and outcome were very similar in the
two groups (Table 2). Patients had an average age of 57.6 years
and an average length of ICU stay of 3.4 days. A slightly higher
admission prevalence of MRSA-positive patients was found in the
intervention phase group (5% versus 4.5%). The average time
from taking specimen to culture notification was 73.6 hours
(median 68.5, range 26.42–157.3) (n = 91) and from taking
specimen to PCR notification was 19.7 hours (median 18.4, range
3.08–52.92) (n = 213).
Swab results are shown in Table 3. Almost all patients had some
screening swabs taken and 77% had at least 2 sets taken, hence
were able to be included in the study. In the control phase, 2.7% of
patients acquired MRSA, compared with 1?3% in the intervention
phase.
Culture and PCR results
There were 5589 swab sets that were processed by culture and
PCR. Of these, 5000 (89.46%) were both culture and PCR
negative, with 158 (2.83%) both positive, 42 (0.75%) culture
positive and PCR negative, 159 (2.84%) culture negative and PCR
positive, 2 (0.04%) culture positive and PCR indeterminate, and
228 (4?08%) culture negative and PCR indeterminate.
71.6% of 239 isolates tested were resistant to erythromycin, with
26.4% sensitive and 2% intermediate. Of the isolates tested,
79.5% of 239 were resistant to ciprofloxacin, with 20.2% sensitive
and the remainder intermediate.
PFGE results
PFGE was performed on 255 isolates from 230 patients
(Figure 1). There were 19 patients with more than one MRSA
isolate typed, with five having more than one PFGE type and none
more than two different types. Overall there were 31 PFGE types
and Figure 1 shows different types present each month. The most
frequently encountered types were A [39/255 (15.3%)], B [55/255
(21.6%)], C [46/255 (18.0%)], L [20/255 (7.8%)], T [15/255
(5.9%)], O [14/255 (5.5%)], and U [10/255 (3.9%)]. We intended
to review PFGE type in cases in which a putative transmission
event occurred (two cases of MRSA in which at least one was a
new acquisition with overlapping time in ICU). Unfortunately
there were insufficient numbers of these events for any inference to
be valid.
Hand hygiene and infection control compliance
There were 6179 hand hygiene compliance opportunities
observed in 351 sessions. Compliance ranged between 12 and
34%. There was a very slight, non-significant trend upwards
throughout the study (see Figure S1). Compliance with infection
control precautions was observed in 3761 opportunities in 342
sessions. Gloves were worn when required in 698/795 (87.8%)
observations in the control phase and in 622/722 (86.2%) in the
intervention phase (P= 0.3). Long sleeved gowns were worn when
required in 109/120 (90.8%) opportunities in the control phase
and 208/235 (88.5%) in the intervention phase (P= 0.5).
Primary analysis
After accounting for the a priori determined covariates given in
Table 4, the hazard ratio of MRSA acquisition in the intervention
phase was significantly lower than in the control phase, with a
hazard ratio of 0?39 during the intervention compared with
control (95% CI 0.24 to 0.62).
Secondary analysis
On univariate analysis, being in the control phase of the study,
prior exposure to anaerobically active antibiotics and high ward
colonization pressure were associated with increased daily risk of
MRSA acquisition. Higher numbers of beds occupied on the ward
and being a cardiothoracic surgical patient was associated with
reduced MRSA acquisition. On multivariate analysis, being in the
control phase of the study, prior exposure to anaerobically active
antibiotics and high ward colonization pressure continued to be
Prevention of MRSA Infection in ICU Patients
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significantly associated with increased daily risk of acquisition. All
other covariates were non-significant, as shown in Table 4.
Segmented regression
Figure 2 shows the monthly incidence of MRSA incidence over
the study. The mean number of MRSA acquisitions per month
was 3.0, variance 5.4. The value of the variance on the mean of
Table 2. Patient characteristics.
Phase 1 Phase 2
2183 patients 2196 patients
2387 admissions 2394 admissions
Average age (years) (n = 2377) (n = 2381)
(median, range) 57?6 57?7
(61, 15–98) (61, 15–101)
Average ICU length of stay (days) (n = 2387) (n = 2394)
(median, range) 3?2 3?4
(2, ,1–75) (2, ,1–86)
Gender (n = 2387) (n = 2392)
Female 868 (36?4%) 841 (35?2%)
Medical Unit (n = 2374) (n = 2359)
CT surgery 717 (30?2%) 688 (29?1%)
Medical 784 (33?0%) 768 (32?6%)
Other surgery 525 (22?1%) 536 (22?7%)
Trauma 348 (14?7%) 367 (15?6%)
Median APACHEII (n = 2370) (n = 2374)
(range) 13 (0 to 47) 14 (1 to 50)
Percentage of time MRSA colonized patients in contact precautions 7?3%* 76?4%
Percentage of time MRSA colonized patients in single rooms or cohorted 18?5%* 46?5%
*Patients were in contact precautions or single room/cohorted for reasons other than MRSA.
Denominators may vary if data were missing.
doi:10.1371/journal.pone.0058112.t002
Table 3. Swab results.
$2 sets of swabs taken per admission (n = 2374) (n = 2366)
1819 (76?6%) 1822 (77?0%)
Mean number of swabs taken (median, range) (n = 2353) (n = 2346)
2?3 (2, 1–24) 2?4 (2, 1–27)
Screening swabs taken (n = 2387) (n = 2394)
2374 (99?5%) 2366 (98?8%)
MRSA positive at admission (previous +ve or screening swab +ve) (n = 2374) (n = 2366)
108 (4?5%) 118 (5?0%)
Any MRSA screening/clinical sample positive (n = 2374) (n = 2366)
155 (6?5%) 126 (5?3%)
Infections caused by MRSA (n = 2353) (n = 2343)
29 (1.2%) 30 (1.3%)
Number of MRSA acquisitions (n* = 2173) (n* = 2135)
58 (2?7%) 27 (1?3%)
Rate of acquisition (per 1000 at risk patient days) (n** = 3136) (n** = 3430)
18?5 7?9
*Patients at risk.
**Days at risk.
Denominators may vary if data were missing.
doi:10.1371/journal.pone.0058112.t003
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1.8 supports extra-Poisson variation. We used a model of
segmented regression, allowing for a step change at the time of
the intervention, and estimated parameters based on an assumed
proportional reduction (or increase) month by month. The
incidence of MRSA acquisition is estimated to have been
approximately flat during the control phase of the study, at 7
Figure 1. PFGE subtypes.
doi:10.1371/journal.pone.0058112.g001
Table 4. Hazard ratios for covariates associated with MRSA acquisition.
Univariate Analysis Multi-variate analysis
Predictor Variable Hazard Ratio P-value 95%CI Hazard Ratio P-value 95%CI
Intervention phase 0.42 ,0.001 0.26 0.66 0.39 ,0.001 0.24 0.62
Age .70 1.03 0.92 0.63 1.67 1.13 0.63 0.68 1.87
Gender =male 1.36 0.20 0.85 2.16 1.44 0.12 0.91 2.29
Apache score .18 0.96 0.86 0.61 1.51 0.93 0.77 0.59 1.48
Cardiothoracic patient 0.41 0.04 0.17 0.97 0.54 0.23 0.20 1.47
Patient to Nurse Ratio higher than 1:1 1.03 0.93 0.51 2.07 1.20 0.63 0.57 2.53
Number of beds occupied.25 0.59 0.05 0.35 0.99 0.77 0.34 0.45 1.31
Colonization pressure high: 2 or more 1.77 0.01 1.14 2.73 1.73 0.02 1.11 2.69
Prior exposure to:
Penicillin/Amoxycillin 1.10 0.77 0.58 2.08 0.79 0.45 0.43 1.45
Anaerobic activity 2.44 ,0.001 1.60 3.73 2.42 ,0.001 1.52 3.86
Broad Spectrum 0.84 0.51 0.51 1.40 0.85 0.54 0.51 1.42
MSSA active agent 0.61 0.16 0.30 1.22 0.78 0.53 0.36 1.68
MRSA active agent 0.84 0.46 0.54 1.33 1.05 0.85 0.66 1.66
Quinolones 0.87 0.79 0.32 2.39 0.77 0.62 0.27 2.17
Cephalosporins 1.31 0.33 0.76 2.24 1.08 0.79 0.59 1.98
doi:10.1371/journal.pone.0058112.t004
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acquisitions per 1000 at-risk patient days (estimate of monthly
decrease of 0.1%, 95% CI= 3.5% reduction to 4.5% increase each
month). There was an observed decline in incidence during the
intervention phase of 7% each month, which was statistically
significant (95% CI= 12.8% reduction to 1.9% reduction). At the
time immediately after the introduction of the intervention, we
estimate that the number of acquisitions reduced by 2.1 per 1000
at-risk patient days which was not statistically significant (95% CI
26.0 to +1.6 per 1000 at risk patient days).
Comparison of nosocomial MRSA and MSSA bacteraemia
rates during the study period
During the study period, data on Staphylococcus aureus bacterae-
mias were collected in the ICU and throughout the hospital.
Numbers were too small for meaningful comparison in the ICU
however the hospital-wide rates were examined and are given in
the Figures S3 and S4. The rates of nosocomial MSSA
bacteraemia throughout the hospital were 7.0 per 10,000 patient
days, with a trend toward an increase in MSSA bacteraemia in the
intervention phase of the study (no change in slope null hypothesis
P = 0.06). The rates of nosocomial MRSA bacteraemia were stable
at approximately 2.3 per 10,000 patient days (no change in slope
null hypothesis, P = 0.6).
Additional analyses
The File S1 contains the sensitivity analysis. Figure S1 reports
hand hygiene throughout the study period and Figures S2 and S3
report fidelity of the hospital staff to study interventions. Figures
S4 and S5 show rates of MRSA and MSSA bacteraemia.
Discussion
We found a 60% reduction in acquisition of MRSA in the ICU
during an intervention in which MRSA colonized patients were
identified using rapid molecular detection methods and managed
using contact precautions and isolation/cohorting. This study is
unique as it tested a single intervention that was instituted as a
planned prospective research study, with the analysis taking into
account serial dependence that inevitably occurs when studying
communicable diseases in a confined setting. Segmented regres-
sion demonstrated that there was no trend in MRSA acquisition
rates prior to the intervention phase, but there was both a drop in
acquisition rates immediately after the intervention and further
decline during the intervention phase.
Figure 2. Segmented regression model. Incidence of MRSA per 1000 at risk patient days in ICU over the study period. There was a
decline in MRSA acquisition of 7% per month in the intervention phase, which was a significant change in slope compared with the control phase
(95% CI for change in slope 1.9 to 12.8% reduction). The dark blue lines are the data, the black lines are the model best fit results and the light blue
lines are the upper and lower values of the 95% credible intervals for the model estimates.
doi:10.1371/journal.pone.0058112.g002
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The secondary findings from this study are of interest, but are
not intended to suggest causal associations. Anaerobically active
agents were the only antibiotic class that was associated with
MRSA acquisition in the multivariate analysis. This is unexpected,
but may suggest an effect on resident flora, as has been shown with
VRE [25]. The association of high bed occupancy with reduced
MRSA acquisition warrants further consideration. High ward
occupancy may lead to fewer contacts per patient which has been
predicted by some models to lead to lower transmission of
infection [23].
PFGE of the MRSA isolates showed the presence of multiple
clones with several predominating at different times. Therefore
there appears to be no outbreak of a single PFGE type during the
study, but rather importation (and possibly onward transmission)
of several types. This is not unexpected given the relatively low
acquisition rate compared with the admission prevalence.
We employed research nurses to optimise compliance with the
intervention. This however, means that the results may not be
generalizable to other institutions where this level of support is not
available.
A number of studies have examined the utility of active
surveillance with conflicting results [26,27], but we have found no
studies testing contact precautions in the context of rapid detection
as a single intervention in a prospective, systematic way. Most of
the publications reporting effectiveness of contact precautions used
them as one of multiple serial interventions in observational
outbreak reports [28,29]. One previous study found that patients
in single room isolation had no less MRSA acquisition than those
cohorted, but that study did not incorporate rapid diagnosis and
contact precautions [21].
A recent cluster randomised trial found that use of active
surveillance with expanded contact precautions did not reduce
transmission of MRSA [9]. Although this methodology is regarded
as the optimal study design, that study had high baseline variation
in transmission rates and delays in screening, which reduced its
power. Although our study was only performed at a single centre,
it took into account serial dependence, bias and clustering in the
analysis by incorporating colonization pressure into the daily
hazard analysis.
It is interesting to speculate how this intervention is associated
with reduction in MRSA acquisition. In the intervention phase,
MRSA patients spent 76.4% of their time in contact precautions
and 46.5% in single rooms from the date of their first positive swab
(or admission date if they were known to be colonized). Although
this was less than the study aimed to achieve, the time in contact
precautions was substantially higher than in the control phase, and
it may have been sufficient to account for a reduction in
transmission, akin to models examining improved but imperfect
hand hygiene compliance [30]. The study design cannot exclude
temporal effects or a Hawthorne effect. However, it should be
noted that the number of colonized patients entering the ICU was
slightly higher in the intervention phase than the control phase,
that hand hygiene compliance did not significantly change and no
other interventions took place during the study.
A finding of efficacy of rapid detection and isolation/cohorting
and contact precautions does not lead the authors to conclude
necessarily that this intervention is essential. The costs, labour, and
time requirements of this intervention were considerable. A cost-
benefit analysis is currently being performed to evaluate this
intervention compared with other general intervention measures.
Adverse effects of isolation are not insignificant and need to be
taken into account as well.
The value of the current pathogen-specific intervention is likely
to be contingent on local context such as background rates of
MRSA colonization and infection and community-associated
MRSA rates and ability to detect MRSA and institute contact
precautions rapidly. The most recent data reported to the National
Healthcare Safety Network showed that MRSA was responsible
for only 8% of device- and procedure- associated healthcare-
associated infections (HAIs) [31]. The intervention in this study
was 60% effective, having a potential effect of reducing total HAIs
by only 5%. Thus, any intervention directed at MRSA alone will
only have a small effect on the total number of HAIs, as has been
suggested previously [3].
Generic population measures that reduce the incidence of HAIs
caused by all organisms, such as enhanced hand hygiene,
antibiotic stewardship, environmental cleaning and bundles of
care [32], have greater potential to reduce HAIs. The authors
recommend that proven generic measures be adopted as a priority
and the decision to adopt pathogen-specific screening and contact
isolation be made according to local context including relative
burden of MRSA and available resources.
Supporting Information
Figure S1 Hand hygiene compliance throughout the
study period.
(TIF)
Figure S2 Use of single rooms or cohort over the study
period. The Y axis shows the number of colonized patients in the
ward as the height of the stacked bar plot. The colonized patients
put into single rooms or cohorted are shown in blue, while those
not in single rooms are shown in red.
(TIF)
Figure S3 Use of contact precautions over the study
period. The Y axis shows the proportion of patients in contact
precautions over the study period.
(TIF)
Figure S4 Rate of MSSA infection in the hospital during
the study period. There was a non-significant trend to
increasing MSSA over the study period P= 0.06.
(TIF)
Figure S5 Rate of MRSA infection in the hospital during
the study period. The rates of MRSA bacteraemia were stable
P= 0.6.
(TIF)
File S1 Supporting information file. The Supporting
Information file contains the sensitivity analysis.
(DOCX)
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